BETHESDA, MD 09 October 2012—Hospira Inc. recently recalled one lot of lactated Ringer's and 5% dextrose injection, according to an announcement circulated by FDA's MedWatch program.
A copy of the company's press release states that a customer reported receiving Lactated Ringer's and 5% Dextrose Injection, USP, packaged in a 1000-mL flexible container, that appeared to be contaminated with mold.
According to the press release, a leak was found in the flexible container's outlet port, between the port's removable cap and the fill-tube seal. Any leakage might have remained within the container's nonsterile overwrap, possibly reentering the flexible container, the company said.
The recall applies to lot 12-160-JT, which expires December, 1, 2013. The lot number may be followed by 01 or 90, according to the press release.
Hospira stated that the product was distributed throughout the United States, except for Alaska, from January through June of this year.
Hospira asked all customers who have the recalled solution to quarantine it immediately and contact Stericycle (877-650-7688, 8:00 am to 5:00 pm EST, Monday through Friday), to arrange for the return and replacement of the product.